Central Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

A detailed history of Central Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Central Trust CO holds 1,445 shares of REGN stock, worth $1.09 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,445

Previous 1,778 18.73%

Holding current value

$1.09 Million

Previous $1.87 Million 18.68%

% of portfolio

0.04%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$1024.09 - $1201.76 $341,021 - $400,186	-333 Reduced 18.73%	1,445 $1.52 Million
Q2 2024 Aug 05, 2024	SELL	$883.2 - $1071.19 $117,465 - $142,468	-133 Reduced 6.96%	1,778 $1.87 Million
Q1 2024 Apr 24, 2024	SELL	$902.69 - $993.35 $55,064 - $60,594	-61 Reduced 3.09%	1,911 $1.84 Million
Q4 2023 Jan 24, 2024	SELL	$775.18 - $881.7 $89,145 - $101,395	-115 Reduced 5.51%	1,972 $1.73 Million
Q3 2023 Oct 26, 2023	SELL	$692.45 - $844.37 $424,471 - $517,598	-613 Reduced 22.7%	2,087 $1.72 Million
Q2 2023 Jul 26, 2023	SELL	$700.03 - $830.35 $686,729 - $814,573	-981 Reduced 26.65%	2,700 $1.94 Million
Q1 2023 Apr 19, 2023	SELL	$680.49 - $826.97 $556,640 - $676,461	-818 Reduced 18.18%	3,681 $3.02 Million
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $230,120 - $249,843	-326 Reduced 6.76%	4,499 $0
Q3 2022 Nov 17, 2022	SELL	$573.97 - $724.32 $41,325 - $52,151	-72 Reduced 1.47%	4,825 $3.32 Million
Q2 2022 Aug 09, 2022	SELL	$548.35 - $738.84 $1.05 Million - $1.41 Million	-1,907 Reduced 28.03%	4,897 $2.89 Million
Q1 2022 May 03, 2022	BUY	$595.12 - $698.43 $116,643 - $136,892	196 Added 2.97%	6,804 $4.75 Million
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $35,326 - $43,613	-65 Reduced 0.97%	6,608 $4.17 Million
Q3 2021 Oct 19, 2021	BUY	$574.03 - $680.96 $128,008 - $151,854	223 Added 3.46%	6,673 $4.04 Million
Q2 2021 Jul 23, 2021	SELL	$472.8 - $558.54 $331,905 - $392,095	-702 Reduced 9.82%	6,450 $3.6 Million
Q1 2021 Apr 23, 2021	BUY	$446.73 - $548.2 $2.01 Million - $2.47 Million	4,502 Added 169.89%	7,152 $3.38 Million
Q4 2020 Jan 29, 2021	SELL	$478.3 - $607.98 $262,586 - $333,781	-549 Reduced 17.16%	2,650 $1.28 Million
Q3 2020 Oct 22, 2020	SELL	$544.75 - $658.21 $6,537 - $7,898	-12 Reduced 0.37%	3,199 $1.79 Million
Q2 2020 Jul 14, 2020	BUY	$493.32 - $643.92 $48,838 - $63,748	99 Added 3.18%	3,211 $2 Million
Q1 2020 Apr 17, 2020	BUY	$336.18 - $494.43 $12,438 - $18,293	37 Added 1.2%	3,112 $1.52 Million
Q4 2019 Jan 21, 2020	SELL	$274.13 - $376.51 $25,768 - $35,391	-94 Reduced 2.97%	3,075 $1.15 Million
Q3 2019 Oct 28, 2019	SELL	$273.46 - $318.39 $546,646 - $636,461	-1,999 Reduced 38.68%	3,169 $879,000
Q2 2019 Jul 12, 2019	BUY	$299.6 - $414.82 $831,090 - $1.15 Million	2,774 Added 115.87%	5,168 $0
Q1 2019 Apr 26, 2019	BUY	$372.08 - $439.57 $876,992 - $1.04 Million	2,357 Added 6370.27%	2,394 $0
Q4 2017 Jan 23, 2018	SELL	$358.63 - $469.95 $10,400 - $13,628	-29 Reduced 43.94%	37 $0
Q3 2017 Oct 17, 2017	BUY	$431.38 - $504.0 $28,471 - $33,264	66	66 $0

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account